Differential role of dopamine in emotional attention and memory: Evidence from Parkinson's disease

Movement Disorders

Volumn 26, Issue 9, 2011, Pages 1677-1683

  Hälbig, Thomas D ^a,b   Assuras, Stephanie ^a   Creighton, Judy ^a   Borod, Joan C ^a,c   Tse, Winona ^a   Frisina, Pasquale G ^a,d   Voustianiouk, Andrei ^e   Gracies, Jean Michel ^a   Olanow, C Warren ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c CITY UNIVERSITY OF NEW YORK   (United States)

^d KESSLER INSTITUTE FOR REHABILITATION   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basal ganglia; Dopamine; Emotional processing; Memory; Parkinson's disease

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

ADULT; AROUSAL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; EMOTION; FEMALE; HUMAN; LATENT PERIOD; MALE; MEMORY; NEUROMODULATION; PARKINSON DISEASE; PRIORITY JOURNAL; VISUAL STIMULATION;

AGED; ANALYSIS OF VARIANCE; ATTENTION; CASE-CONTROL STUDIES; DOPAMINE AGENTS; EMOTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PHOTIC STIMULATION; REACTION TIME; RECOGNITION (PSYCHOLOGY);

EID: 79961209174     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23728     Document Type: Article

References (41)

1. Frank MJ, Seeberger LC, O'Reilly RC. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 2004; 306: 1940-1943.
2. Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 2006; 442: 1042-1045.
3. Schultz W, Tremblay L, Hollerman JR. Reward processing in primate orbitofrontal cortex and basal ganglia. Cereb Cortex 2000; 10: 272-284.
4. Badgaiyan RD, Fischman AJ, Alpert NM. Dopamine release during human emotional processing. Neuroimage 2009; 47: 2041-2045.
5. Ouchi Y, Yoshikawa E, Okada H, et al. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography. Ann Neurol 1999; 45: 601-610.
6. Tessitore A, Hariri AR, Fera F, et al. Dopamine modulates the response of the human amygdala: a study in Parkinson's disease. J Neurosci 2002; 22: 9099-9103.
7. Adolphs R. Neural systems for recognizing emotion. Curr Opin Neurobiol 2002; 12: 169-177.
8. Borod JC, Welkowitz J, Alpert M, et al. Parameters of emotional processing in neuropsychiatric disorders: conceptual issues and a battery of tests. J Commun Disord 1990; 23: 247-271.
9. Bowers D, Miller K, Mikos A, et al. Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli. Brain 2006; 129: 3356-3365.
10. Yip JT, Lee TM, Ho SL, Tsang KL, Li LS. Emotion recognition in patients with idiopathic Parkinson's disease. Mov Disord 2003; 18: 1115-1122.
11. Adolphs R, Schul R, Tranel D. Intact recognition of facial emotion in Parkinson's disease. Neuropsychology 1998; 12: 253-258.
12. Bradley MM, Greenwald MK, Petry MC, Lang PJ. Remembering pictures: pleasure and arousal in memory. J Exp Psychol Learn Mem Cogn 1992; 18: 379-390.
13. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
14. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
15. Cahill L, Prins B, Weber M, McGaugh JL. Beta-adrenergic activation and memory for emotional events. Nature 1994; 371: 702-704.
16. Quirarte GL, Roozendaal B, McGaugh JL. Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci U S A 1997; 94: 14048-14053.
17. Lang P, Bradley M, Cuthbert B. International affective picture system (IAPS): Instruction manual and affective ratings. Gainesville, FL: The Center for Research in Psychophysiology, University of Florida, 2001.
18. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971; 9: 97-113.
19. Fahn S, Elton R. Unified Parkinson's Disease Rating Scale. In: Goldstein M, ed. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Health Care Information, 1987: 153-163, 293-304.
20. Spitzer R, Kroenke K, Williams J, Group PHQPCS. Validation and Utility of a Self-report Version of PRIME-MD. JAMA 1999; 282: 1737-1744.
21. Gotham AM, Brown RG, Marsden CD. Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 1986; 49: 381-389.
22. Charles ST, Mather M, Carstensen LL. Aging and emotional memory: the forgettable nature of negative images for older adults. J Exp Psychol 2003; 132: 310-324.
23. Gibbs AA, Naudts KH, Spencer EP, David AS. The role of dopamine in attentional and memory biases for emotional information. Am J Psychiatry 2007; 164: 1603-1609; quiz 1624.
24. Halbig TD, Kopp UA, Wodarz F, et al. Dopaminergic modulation of emotional memory in Parkinson's disease. J Neural Transm 2008; 115: 1159-1163.
25. Kulisevsky J, Garcia-Sanchez C, Berthier ML, et al. Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients. Mov Disord 2000; 15: 613-626.
26. Williams JM, Mathews A, MacLeod C. The emotional Stroop task and psychopathology. Psychol Bull 1996; 120: 3-24.
27. Schroder C, Mobes J, Schutze M, et al. Perception of emotional speech in Parkinson's disease. Mov Disord 2006; 21: 1774-1778.
28. Bjorklund A, Dunnett SB. Dopamine neuron systems in the brain: an update. Trends Neurosci 2007; 30: 194-202.
29. Delaveau P, Salgado-Pineda P, Micallef-Roll J, Blin O. Amygdala activation modulated by levodopa during emotional recognition processing in healthy volunteers: a double-blind, placebo-controlled study. J Clin Psychopharmacol 2007; 27: 692-697.
30. Muller T, Benz S, Bornke C. Delay of simple reaction time after levodopa intake. Clin Neurophysiol 2001; 112: 2133-2137.
31. Wang J, Thomas JR, Stelmach GE. A meta-analysis on cognitive slowing in Parkinson's disease: are simple and choice reaction times differentially impaired? Parkinsonism Relat Disord 1998; 4: 17-29.
32. Kulisevsky J. Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease. Drugs Aging 2000; 16: 365-379.
33. Williams GV, Goldman-Rakic PS. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 1995; 376: 572-575.
34. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
35. Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999; 122: 1437-1448.
36. Cools R, Barker RA, Sahakian BJ, Robbins TW. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 2001; 11: 1136-1143.
37. Gotham AM, Brown RG, Marsden CD. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 1988; 111: 299-321.
38. Kulisevsky J, Avila A, Barbanoj M, Antonijoan R, Berthier ML, Gironell A. Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels. Brain 1996; 119: 2121-2132.
39. Delaveau P, Salgado-Pineda P, Witjas T, et al. Dopaminergic modulation of amygdala activity during emotion recognition in patients with Parkinson disease. J Clin Psychopharmacol 2009; 29: 548-554.
40. Hall J, Harris JM, McKirdy JW, Johnstone EC, Lawrie SM. Emotional memory in schizophrenia. Neuropsychologia 2007; 45: 1152-1159.
41. Kulisevsky J, Pascual-Sedano B, Barbanoj M, Gironell A, Pagonabarraga J, García-Sánchez C. Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: a double-blind study. Mov Disord 2007; 22: 62-67.